# Aflibercept

## Eylea aflibercept 2mg/0.05mL

| TAH Drug Code      | [IEYL](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IEYL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of neovascular (wet) age-related macular degeneration (AMD).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | Wet type (Neovascular) of age-related macular degeneration (wAMD): 2 mg every 4 weeks for the first 3 injections then every 8 weeks thereafter. Macular edema following central retinal vein occlusion (CRVO): 2 mg every 4 weeks via IVIA. Diabetic macular edema: 2 mg every 4 weeks for the first 5 injections, followed by 2 mg every 8 weeks. Macular edema induced visual impairment following branch retinal vein occlusion (BRVO): 2 mg every 4 weeks for the first 6 injections, followed by 2 mg every 8 weeks. Choroidal neovascularization(CNV) following pathological myopia: 2 mg single dose via IVIA. May repeat 1 to 3 times a year with the 1 month- interval according to the doctor's judgment on vision and/or anatomy. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | 1.Ocular or periocular infection 2.Active intraocular inflammation 3.Hypersensitivity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Adverse Effects    | Common: Blurred vision (1-7%), Cataract (Adult, up to 19%; pediatric, 1%), Conjunctival hemorrhage (Adult, 1-31%; pediatric, 5-9%), Corneal erosion (1-7%), Foreign body sensation, In eyes (Up to 4%), Pain in eye (4-13%), Retinal hemorrhage (1-4%), Visual discomfort, Vitreous floaters (1-8%) Serious: Myocardial infarction, Arterial thrombosis (0.4-6.4%), Hypersensitivity reaction (Less than 1%), Cerebrovascular accident, Endophthalmitis (Less than 1%), Raised intraocular pressure (1-9%), Retinal detachment (Up to 6%), Retinal pigment epithelial detachment (1-5%), Retinal venous tortuosity, Vitreous detachment (1-8%)                                                                                               |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/aflibercept-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

